GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Resp. Med. 8, 585–596 (2020). A key study highlighting the global importance of respiratory diseases.
GBD Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 5, 691–706 (2017).
Duan, K. I. et al. Health care spending on respiratory diseases in the United States, 1996–2016. Am. J. Resp. Crit. Care Med. 207, 183–192 (2023).
Spencer, L. G., Loughenbury, M., Chaudhuri, N., Spiteri, M. & Parfrey, H. Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019. ERJ Open Res. 7, 00187–2020 (2021).
Article PubMed PubMed Central Google Scholar
Navaratnam, V. et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 66, 462–467 (2011).
Article CAS PubMed Google Scholar
Palmer, L. J. et al. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur. Resp. J. 17, 696–702 (2001).
Wilk, J. B. et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet. Epidemiol. 19, 81–94 (2000).
Article CAS PubMed Google Scholar
Shrine, N. et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat. Genet. 51, 481–493 (2019).
Article CAS PubMed PubMed Central Google Scholar
Sakornsakolpat, P. et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat. Genet. 51, 494–505 (2019).
Article CAS PubMed PubMed Central Google Scholar
Wain, L. V. et al. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nat. Genet. 49, 416–425 (2017).
Article CAS PubMed PubMed Central Google Scholar
Repapi, E. et al. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 42, 36–44 (2010).
Article CAS PubMed Google Scholar
Cho, M. H. et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Resp. Med. 2, 214–225 (2014).
Soler Artigas, M. et al. Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation. Nat. Commun. 6, 8658 (2015).
Wain, L. V. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Resp. Med. 3, 769–781 (2015). This study was the first GWAS in the UK Biobank.
Hobbs, B. D. et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat. Genet. 49, 426–432 (2017).
Article CAS PubMed PubMed Central Google Scholar
Zhao, X. et al. Whole genome sequence analysis of pulmonary function and COPD in 19,996 multi-ethnic participants. Nat. Commun. 11, 5182 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
King, E. A., Davis, J. W. & Degner, J. F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 15, e1008489 (2019).
Article PubMed PubMed Central Google Scholar
Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856–860 (2015). This influential study showed that supporting genetic data contributes to successful drug development.
Article CAS PubMed Google Scholar
Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415–1424 (2021). This paper provided a description of the degree of relationship between phenotypes using GWAS data.
Article CAS PubMed Google Scholar
Zhou, Y. H. et al. Genetic modifiers of cystic fibrosis lung disease severity: whole-genome analysis of 7,840 patients. Am. J. Resp. Crit. Care Med. 207, 1324–1333 (2023).
Article CAS PubMed Google Scholar
Rhodes, C. J. et al. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Resp. Med. 7, 227–238 (2019).
Shrine, N. et al. Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk. Nat. Genet. 55, 410–422 (2023). This study is the largest so far to assess lung-function phenotypes using GWASs and integrated genomics.
Article CAS PubMed PubMed Central Google Scholar
Hancock, D. B. et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 42, 45–52 (2010).
Article CAS PubMed Google Scholar
Herwig, R., Hardt, C., Lienhard, M. & Kamburov, A. Analyzing and interpreting genome data at the network level with ConsensusPathDB. Nat. Protoc. 11, 1889–1907 (2016).
Article CAS PubMed Google Scholar
Lange, P. et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N. Engl. J. Med. 373, 111–122 (2015). This important epidemiological study revealed the origins of COPD risk in early life.
Article CAS PubMed Google Scholar
Hardin, M. et al. A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease. Pharmacogenom. J. 16, 326–335 (2016).
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26–31 (2019).
Article CAS PubMed PubMed Central Google Scholar
Magi, R. et al. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution. Hum. Mol. Genet. 26, 3639–3650 (2017). This study emphasized the value of trans-ethic approaches for GWASs.
Article CAS PubMed PubMed Central Google Scholar
Sollis, E. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, D977–D985 (2023).
Article CAS PubMed Google Scholar
Regan, E. A. et al. Genetic epidemiology of COPD (COPDGene) study design. J. COPD 7, 32–43 (2010). This paper reports a description of the COPDGene study design.
Ragland, M. F. et al. 10-year follow-up of lung function, respiratory symptoms, and functional capacity in the COPDGene study. Ann. Am. Thorac. Soc. 19, 381–388 (2022).
Article PubMed PubMed Central Google Scholar
Joo, J., Hobbs, B. D., Cho, M. H. & Himes, B. E. Trait insights gained by comparing genome-wide association study results using different chronic obstructive pulmonary disease definitions. AMIA Jt Summits Transl. Sci. Proc. 2020, 278–287 (2020).
PubMed PubMed Central Google Scholar
Cho, M. H. et al. A genome-wide association study of emphysema and airway quantitative imaging phenotypes. Am. J. Resp. Crit. Care Med. 192, 559–569 (2015). This GWAS included imaging phenotypes in COPD.
Article CAS PubMed PubMed Central Google Scholar
Busch, R. et al. Genetic association and risk scores in a chronic obstructive pulmonary disease meta-analysis of 16,707 subjects. Am. J. Resp. Cell Mol. Biol. 57, 35–46 (2017).
North, T. L. et al. A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for α1-antitrypsin deficiency increases respiratory capacity and height. J. Med. Genet. 53, 280–288 (2016).
Article CAS PubMed Google Scholar
Fawcett, K. A. et al. Pleiotropic associations of heterozygosity for the SERPINA1 Z allele in the UK Biobank. ERJ Open Res. 7, 00049–2021 (2021).
Article PubMed PubMed Central Google Scholar
Kim, W. et al. Assessing the contribution of rare genetic variants to phenotypes of chronic obstructive pulmonary disease using whole-genome sequence data. Hum. Mol. Genet. 31, 3873–3885 (2022).
Article CAS PubMed PubMed Central Google Scholar
Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470–473 (2007).
留言 (0)